Table 3.
ACEI/ARBs | B-Blockers | CCBs | ≥ 1 Agent | |||||
---|---|---|---|---|---|---|---|---|
AOR | P -value | AOR | P -value | AOR | P -value | AOR | P -value | |
Age, per 10 yrs | 1.05 | < 0.0001 | 1.05 | < 0.0001 | 1.10 | < 0.0001 | 1.10 | < 0.0001 |
Male sex | 0.98 | 0.51 | 1.06 | 0.035 | 0.95 | 0.034 | 0.93 | 0.0010 |
Race/Ethnicity | ||||||||
Caucasian | 1.0 | − | 1.0 | − | 1.0 | − | 1.0 | − |
African- American | 0.78 | < 0.0001 | 0.69 | < 0.0001 | 0.85 | < 0.0001 | 0.78 | < 0.0001 |
Hispanic | 0.73 | < 0.0001 | 0.56 | < 0.0001 | 0.84 | < 0.0001 | 0.68 | < 0.0001 |
Other | 0.97 | 0.57 | 0.67 | < 0.0001 | 0.84 | 0.0005 | 0.85 | 0.0004 |
Inability to ambulate | 1.16 | 0.052 | 1.13 | 0.10 | 1.08 | 0.29 | 1.10 | 0.13 |
Inability to transfer | 0.61 | 0.0006 | 0.75 | 0.038 | 0.89 | 0.39 | 0.61 | < 0.0001 |
Employed | 1.14 | 0.12 | 1.04 | 0.61 | 1.07 | 0.44 | 1.00 | 0.99 |
BMI category | ||||||||
< 20kg/m2 | 0.95 | 0.25 | 0.99 | 0.81 | 0.90 | 0.024 | 0.90 | 0.017 |
20-24.9kg/m2 | 1.0 | − | 1.0 | − | 1.0 | − | 1.0 | − |
25-29.9kg/m2 | 0.99 | 0.87 | 0.97 | 0.38 | 0.90 | 0.0007 | 0.93 | 0.0085 |
30+ kg/m2 | 0.84 | < 0.0001 | 0.85 | < 0.0001 | 0.79 | < 0.0001 | 0.72 | < 0.0001 |
Smoker | 1.00 | 0.98 | 0.90 | 0.032 | 0.97 | 0.53 | 0.94 | 0.15 |
Substance abuser | 0.97 | 0.66 | 0.90 | 0.15 | 0.95 | 0.51 | 0.92 | 0.24 |
Liu Comorbidity Score2 | 1.02 | 0.47 | 1.05 | 0.12 | 0.93 | 0.020 | 0.99 | 0.79 |
Comorbidities | ||||||||
DM | 1.28 | < 0.0001 | 0.99 | 0.66 | 1.14 | < 0.0001 | 1.23 | < 0.0001 |
CHF | 0.99 | 0.68 | 1.00 | 0.94 | 0.93 | 0.023 | 0.98 | 0.48 |
CAD | 1.00 | 0.96 | 1.31 | < 0.0001 | 0.93 | 0.033 | 1.11 | 0.0003 |
PVD | 1.02 | 0.57 | 0.91 | 0.014 | 0.88 | 0.0014 | 0.93 | 0.057 |
CVA | 1.23 | < 0.0001 | 1.29 | < 0.0001 | 1.25 | < 0.0001 | 1.30 | < 0.0001 |
Hb < 11.0 | 0.93 | 0.012 | 0.90 | 0.0001 | 1.00 | 0.89 | 0.96 | 0.13 |
Self-care dialysis | 0.94 | 0.27 | 0.99 | 0.84 | 0.73 | < 0.0001 | 0.82 | < 0.0001 |
Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor; β-blocker, β-adrenergic antagonist; CCB, calcium channel blocker; statin, AOR, adjusted odds ratios; BMI, body mass index; HTN, hypertension; DM, diabetes; CHF, congestive heart failure; CAD, coronary artery disease; PVD; peripheral vascular disease; CVA, cerebrovascular accident; Hb, hemoglobin.